Company news

InMode Ltd. news in 2025

InMode Ltd.'s news releases, calls and decks from 2025, newest first.

View company

InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins

November 4, 2025

InMode Appoints Michael Dennison as President of North America

November 2, 2025

InMode to Participate in Upcoming Investor Conferences

October 29, 2025

InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M

October 8, 2025

InMode to Present at Baird 2025 Global Healthcare Conference

September 1, 2025

InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins

July 29, 2025

InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M

July 9, 2025

InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025

May 27, 2025

InMode Announces Health Canada Certification of the IgniteRF Platform with the New QuantumRF Technology

May 20, 2025

InMode to Present at Upcoming Investor Conferences and Events

May 6, 2025

InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges

May 5, 2025

InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease

April 27, 2025

InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M

April 13, 2025

InMode to Present at the 24th Annual Needham Virtual Healthcare Conference

March 25, 2025

InMode Responds to Doma Perpetual's Letters

March 5, 2025

InMode to Present at Upcoming Investor Conferences

March 2, 2025

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program

February 3, 2025

InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

February 2, 2025

InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced

January 15, 2025

InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M

January 7, 2025

Calls in 2025

Decks in 2025